Millennium Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6M | Buy |
2,250,497
+1,727,134
| +330% | +$16.6M | 0.01% | 1083 |
|
|
2025
Q1 | $3.28M | Buy |
523,363
+463,372
| +772% | +$2.91M | ﹤0.01% | 2262 |
|
|
2024
Q4 | $487K | Buy |
59,991
+27,063
| +82% | +$220K | ﹤0.01% | 3290 |
|
|
2024
Q3 | $595K | Buy |
+32,928
| New | +$595K | ﹤0.01% | 3209 |
|
|
2024
Q2 | – | Sell |
-225,024
| Closed | -$2.39M | – | 4357 |
|
|
2024
Q1 | $2.39M | Buy |
225,024
+54,980
| +32% | +$584K | ﹤0.01% | 2471 |
|
|
2023
Q4 | $1.55M | Buy |
170,044
+30,696
| +22% | +$280K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $1.45M | Buy |
139,348
+111,407
| +399% | +$1.16M | ﹤0.01% | 2704 |
|
|
2023
Q2 | $400K | Sell |
27,941
-29,922
| -52% | -$428K | ﹤0.01% | 3392 |
|
|
2023
Q1 | $413K | Buy |
+57,863
| New | +$413K | ﹤0.01% | 3520 |
|
|
2022
Q4 | – | Sell |
-50,396
| Closed | -$558K | – | 5096 |
|
|
2022
Q3 | $558K | Buy |
+50,396
| New | +$558K | ﹤0.01% | 3768 |
|
|
2021
Q2 | – | Sell |
-12,090
| Closed | -$454K | – | 5273 |
|
|
2021
Q1 | $454K | Sell |
12,090
-61,287
| -84% | -$2.3M | ﹤0.01% | 3710 |
|
|
2020
Q4 | $2.44M | Buy |
+73,377
| New | +$2.44M | ﹤0.01% | 2395 |
|